SIMILAR PATTERNS OF AMINO ACIDS FOR 3L4W_A_MIGA1001_1
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1zl9 | GLUTATHIONES-TRANSFERASE 5 (Caenorhabditiselegans) |
PF02798(GST_N)PF14497(GST_C_3) | 5 | TYR A 97ILE A 162ILE A 158TRP A 157HIS A 67 | None | 1.18A | 3l4wA-1zl9A:undetectable | 3l4wA-1zl9A:13.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2g3n | ALPHA-GLUCOSIDASE (Sulfolobussolfataricus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 11 | TYR A 184ASP A 212ILE A 213ILE A 249TRP A 284TRP A 318ASP A 320TRP A 413ASP A 416PHE A 449HIS A 480 | BOG A2000 (-4.5A)NoneNoneNoneNoneNoneNoneNoneBOG A2000 (-3.0A)NoneNone | 0.60A | 3l4wA-2g3nA:37.8 | 3l4wA-2g3nA:27.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2g3n | ALPHA-GLUCOSIDASE (Sulfolobussolfataricus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 11 | TYR A 184ASP A 212ILE A 213ILE A 249TRP A 318ASP A 320MET A 321TRP A 413ASP A 416PHE A 449HIS A 480 | BOG A2000 (-4.5A)NoneNoneNoneNoneNoneBOG A2000 ( 4.0A)NoneBOG A2000 (-3.0A)NoneNone | 0.32A | 3l4wA-2g3nA:37.8 | 3l4wA-2g3nA:27.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2q42 | PUTATIVEHYDROXYACYLGLUTATHIONE HYDROLASE 2 (Arabidopsisthaliana) |
PF00753(Lactamase_B)PF16123(HAGH_C) | 5 | TYR A 171ASP A 11ASP A 58ASP A 131PHE A 134 | ACY A 800 ( 4.6A)None FE A 701 (-2.6A) FE A 701 ( 2.4A)ACY A 800 (-4.5A) | 1.31A | 3l4wA-2q42A:undetectable | 3l4wA-2q42A:15.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2qml | BH2621 PROTEIN (Bacillushalodurans) |
PF13523(Acetyltransf_8) | 5 | TYR A 87ASP A 92ILE A 94ILE A 93HIS A 68 | None | 1.30A | 3l4wA-2qmlA:undetectable | 3l4wA-2qmlA:12.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2x2i | ALPHA-1,4-GLUCANLYASE ISOZYME 1 (Gracilariopsislemaneiformis) |
PF01055(Glyco_hydro_31) | 8 | ASP A 412TRP A 551ASP A 553MET A 554TRP A 662ASP A 665PHE A 698HIS A 731 | QPS A1050 (-3.2A)QPS A1050 (-4.8A)QPS A1050 (-3.1A)QPS A1050 (-3.1A)QPS A1050 (-4.6A)QPS A1050 (-2.7A)QPS A1050 (-4.3A)QPS A1050 (-4.3A) | 0.51A | 3l4wA-2x2iA:33.4 | 3l4wA-2x2iA:23.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xvg | ALPHA XYLOSIDASE (Cellvibriojaponicus) |
PF01055(Glyco_hydro_31)PF16338(DUF4968)PF17137(DUF5110) | 7 | ASP A 470TRP A 580ASP A 582TRP A 656ASP A 659PHE A 692HIS A 740 | None | 0.42A | 3l4wA-2xvgA:35.4 | 3l4wA-2xvgA:25.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xvg | ALPHA XYLOSIDASE (Cellvibriojaponicus) |
PF01055(Glyco_hydro_31)PF16338(DUF4968)PF17137(DUF5110) | 5 | ASP A 688ILE A 660ASP A 659ASP A 582HIS A 740 | None | 1.31A | 3l4wA-2xvgA:35.4 | 3l4wA-2xvgA:25.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ctt | MALTASE-GLUCOAMYLASE (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 11 | TYR A 299ASP A 327ILE A 328ILE A 364TRP A 406TRP A 441ASP A 443MET A 444ASP A 542PHE A 575HIS A 600 | 3CU A1001 (-3.6A)3CU A1001 (-2.7A)3CU A1001 ( 3.9A)3CU A1001 (-4.5A)None3CU A1001 (-4.9A)3CU A1001 (-2.7A)3CU A1001 ( 3.9A)3CU A1001 ( 2.5A)3CU A1001 (-4.5A)3CU A1001 (-3.9A) | 0.49A | 3l4wA-3cttA:60.8 | 3l4wA-3cttA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ctt | MALTASE-GLUCOAMYLASE (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 11 | TYR A 299ASP A 327ILE A 328ILE A 364TRP A 441ASP A 443MET A 444TRP A 539ASP A 542PHE A 575HIS A 600 | 3CU A1001 (-3.6A)3CU A1001 (-2.7A)3CU A1001 ( 3.9A)3CU A1001 (-4.5A)3CU A1001 (-4.9A)3CU A1001 (-2.7A)3CU A1001 ( 3.9A)3CU A1001 (-4.6A)3CU A1001 ( 2.5A)3CU A1001 (-4.5A)3CU A1001 (-3.9A) | 0.19A | 3l4wA-3cttA:60.8 | 3l4wA-3cttA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3lpp | SUCRASE-ISOMALTASE (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 11 | ASP A 355ILE A 356ILE A 392TRP A 435TRP A 470ASP A 472MET A 473TRP A 568ASP A 571PHE A 604HIS A 629 | TRS A6001 (-2.9A)TRS A6001 ( 4.0A)NoneTRS A6001 ( 4.6A)NoneTRS A6001 (-3.2A)TRS A6001 ( 3.7A)NoneTRS A6001 ( 3.7A)TRS A6001 (-4.4A)TRS A6001 (-4.2A) | 0.50A | 3l4wA-3lppA:50.3 | 3l4wA-3lppA:57.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3poc | ALPHA-GLUCOSIDASE (Blautia obeum) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 9 | ASP A 197ILE A 198ILE A 234TRP A 271MET A 308TRP A 417ASP A 420PHE A 453HIS A 478 | ACR A 664 (-2.9A)ACR A 664 (-3.5A)NoneACR A 664 (-4.6A)ACR A 664 ( 3.8A)ACR A 664 (-4.6A)ACR A 664 (-2.8A)ACR A 664 (-4.4A)ACR A 664 (-4.2A) | 0.53A | 3l4wA-3pocA:35.7 | 3l4wA-3pocA:24.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3poc | ALPHA-GLUCOSIDASE (Blautia obeum) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 7 | ASP A 197ILE A 198ILE A 234TRP A 271TRP A 305PHE A 453HIS A 478 | ACR A 664 (-2.9A)ACR A 664 (-3.5A)NoneACR A 664 (-4.6A)NoneACR A 664 (-4.4A)ACR A 664 (-4.2A) | 0.84A | 3l4wA-3pocA:35.7 | 3l4wA-3pocA:24.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3top | MALTASE-GLUCOAMYLASE, INTESTINAL (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 6 | ASP A1279ILE A1280MET A1421ASP A1526PHE A1559HIS A1584 | ACR A 1 (-3.2A)ACR A 1 (-4.1A)ACR A 1 (-3.5A)ACR A 1 (-2.8A)ACR A 1 (-4.3A)ACR A 1 (-3.9A) | 1.42A | 3l4wA-3topA:48.6 | 3l4wA-3topA:43.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3top | MALTASE-GLUCOAMYLASE, INTESTINAL (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 12 | TYR A1251ASP A1279ILE A1280ILE A1315TRP A1355TRP A1418ASP A1420MET A1421TRP A1523ASP A1526PHE A1559HIS A1584 | ACR A 1 ( 4.1A)ACR A 1 (-3.2A)ACR A 1 (-4.1A)NoneACR A 1 (-4.4A)NoneACR A 1 (-3.6A)ACR A 1 (-3.5A)ACR A 1 (-4.5A)ACR A 1 (-2.8A)ACR A 1 (-4.3A)ACR A 1 (-3.9A) | 0.62A | 3l4wA-3topA:48.6 | 3l4wA-3topA:43.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3wel | ALPHA-GLUCOSIDASE (Beta vulgaris) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF16863(NtCtMGAM_N) | 11 | ASP A 357ILE A 358ILE A 396TRP A 432TRP A 467ASP A 469MET A 470TRP A 565ASP A 568PHE A 601HIS A 626 | ACR A1001 (-3.0A)ACR A1001 (-3.6A)ACR A1001 (-4.9A)ACR A1001 ( 4.6A)NoneACR A1001 (-3.2A)ACR A1001 (-3.3A)ACR A1001 (-4.8A)ACR A1001 (-2.7A)ACR A1001 (-4.3A)ACR A1001 (-4.1A) | 0.53A | 3l4wA-3welA:49.3 | 3l4wA-3welA:36.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4b9y | ALPHA-GLUCOSIDASE,PUTATIVE, ADG31B (Cellvibriojaponicus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF16338(DUF4968)PF17137(DUF5110) | 5 | ASP A 299ILE A 341ASP A 480PHE A 513HIS A 540 | None | 1.41A | 3l4wA-4b9yA:38.4 | 3l4wA-4b9yA:26.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4b9y | ALPHA-GLUCOSIDASE,PUTATIVE, ADG31B (Cellvibriojaponicus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF16338(DUF4968)PF17137(DUF5110) | 8 | ASP A 299ILE A 341TRP A 410ASP A 412TRP A 477ASP A 480PHE A 513HIS A 540 | None | 0.38A | 3l4wA-4b9yA:38.4 | 3l4wA-4b9yA:26.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4eog | PUTATIVEUNCHARACTERIZEDPROTEIN (Pyrococcusfuriosus) |
PF09455(Cas_DxTHG) | 5 | ILE A 120ILE A 48TRP A 10PHE A 14HIS A 89 | None | 1.32A | 3l4wA-4eogA:undetectable | 3l4wA-4eogA:20.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5djw | ALPHA-GLUCOSIDASE II (Bacteroidesthetaiotaomicron) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF17137(DUF5110) | 5 | ASP A 211TRP A 319ASP A 321ASP A 401PHE A 434 | None | 1.44A | 3l4wA-5djwA:36.1 | 3l4wA-5djwA:28.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5dkx | ALPHAGLUCOSIDASE-LIKEPROTEIN (Chaetomiumthermophilum) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF17137(DUF5110) | 8 | ASP A 443ILE A 444ILE A 480TRP A 517ASP A 556MET A 557PHE A 666HIS A 691 | TRS A1001 (-2.9A)TRS A1001 ( 4.1A)NoneTRS A1001 ( 4.9A)TRS A1001 (-3.2A)TRS A1001 (-3.5A)TRS A1001 (-4.5A)TRS A1001 (-4.0A) | 0.62A | 3l4wA-5dkxA:39.8 | 3l4wA-5dkxA:27.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5dkx | ALPHAGLUCOSIDASE-LIKEPROTEIN (Chaetomiumthermophilum) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF17137(DUF5110) | 10 | ASP A 443ILE A 444ILE A 480TRP A 554ASP A 556MET A 557TRP A 630ASP A 633PHE A 666HIS A 691 | TRS A1001 (-2.9A)TRS A1001 ( 4.1A)NoneTRS A1001 (-4.9A)TRS A1001 (-3.2A)TRS A1001 (-3.5A)NoneTRS A1001 (-2.8A)TRS A1001 (-4.5A)TRS A1001 (-4.0A) | 0.39A | 3l4wA-5dkxA:39.8 | 3l4wA-5dkxA:27.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f7c | ALPHA-GLUCOSIDASE (Bacteroidesthetaiotaomicron) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 6 | ASP A 348ASP A 460TRP A 520ASP A 523PHE A 556HIS A 588 | None | 0.39A | 3l4wA-5f7cA:28.6 | 3l4wA-5f7cA:23.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f7s | GLYCOSIDE HYDROLASEFAMILY 31 (Trueperellapyogenes) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 5 | ASP A 467TRP A 529ASP A 532PHE A 565HIS A 591 | CA A 805 (-2.9A)None CA A 805 ( 4.6A)NoneNone | 0.53A | 3l4wA-5f7sA:30.9 | 3l4wA-5f7sA:22.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5hjr | NEUTRALALPHA-GLUCOSIDASE AB (Mus musculus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 9 | ASP A 451ILE A 452ILE A 488TRP A 525ASP A 564MET A 565TRP A 637PHE A 673HIS A 698 | 5GF A1021 (-2.0A)5GF A1021 (-3.6A)None5GF A1021 (-3.7A)5GF A1021 (-2.1A)5GF A1021 (-2.6A)5GF A1021 ( 4.6A)5GF A1021 (-3.6A)5GF A1021 (-4.0A) | 0.65A | 3l4wA-5hjrA:42.8 | 3l4wA-5hjrA:30.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5hjr | NEUTRALALPHA-GLUCOSIDASE AB (Mus musculus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 10 | ASP A 451ILE A 452ILE A 488TRP A 562ASP A 564MET A 565TRP A 637ASP A 640PHE A 673HIS A 698 | 5GF A1021 (-2.0A)5GF A1021 (-3.6A)None5GF A1021 (-4.6A)5GF A1021 (-2.1A)5GF A1021 (-2.6A)5GF A1021 ( 4.6A)5GF A1021 (-2.6A)5GF A1021 (-3.6A)5GF A1021 (-4.0A) | 0.46A | 3l4wA-5hjrA:42.8 | 3l4wA-5hjrA:30.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jou | ALPHA-XYLOSIDASEBOGH31A (Bacteroidesovatus) |
PF01055(Glyco_hydro_31)PF16338(DUF4968)PF17137(DUF5110) | 7 | ASP A 441TRP A 551ASP A 553TRP A 627ASP A 630PHE A 663HIS A 709 | EDO A1008 (-2.8A)NoneEDO A1008 (-2.7A)NoneEDO A1008 (-3.0A)EDO A1008 (-4.3A)EDO A1008 (-4.0A) | 0.32A | 3l4wA-5jouA:35.2 | 3l4wA-5jouA:23.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5nn8 | LYSOSOMALALPHA-GLUCOSIDASE (Homo sapiens) |
no annotation | 10 | ASP A 404ILE A 441TRP A 481TRP A 516ASP A 518MET A 519TRP A 613ASP A 616PHE A 649HIS A 674 | ACR A1015 (-3.0A)ACR A1015 (-4.3A)ACR A1015 ( 4.6A)NoneACR A1015 (-3.1A)ACR A1015 (-3.3A)ACR A1015 (-4.8A)ACR A1015 (-2.7A)ACR A1015 (-4.3A)ACR A1015 (-4.0A) | 0.50A | 3l4wA-5nn8A:51.1 | 3l4wA-5nn8A:44.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5x7s | GLYCOSIDE HYDROLASEFAMILY 31ALPHA-GLUCOSIDASE (Paenibacillussp. 598K) |
PF01055(Glyco_hydro_31)PF16338(DUF4968)PF16990(CBM_35)PF17137(DUF5110) | 6 | TRP A 427ASP A 429TRP A 488ASP A 491PHE A 533HIS A 565 | None | 0.43A | 3l4wA-5x7sA:11.4 | 3l4wA-5x7sA:21.10 |